Built for — Pharmaceuticals & Life Sciences
GxP-aware assessment for AI in regulated workflows.
From drug discovery to pharmacovigilance to medical affairs, AI is touching GxP-adjacent workflows. MaacVerify provides independent assessment evidence aligned with FDA, EMA, and ICH expectations on computerized systems and AI/ML.
What's changing
The pressures on pharmaceuticals & life sciences teams.
GxP & CSV expectations
AI vendors rarely produce validation packages that survive a quality audit.
Pharmacovigilance accuracy
Adverse event detection AI directly affects patient safety reporting.
Regulatory submissions
Sponsors increasingly need to describe AI used in evidence generation.
How MaacVerify helps
Independent, audit-defensible evidence — tailored to Pharmaceuticals & Life Sciences.
01
Domain-expert review
Pharma scientists and quality experts assess fitness for the specific GxP-adjacent use.
02
Validation-grade documentation
Assessment artifacts compatible with your CSV and quality management framework.
03
Submission-ready evidence
Records you can reference in regulatory interactions and sponsor due diligence.
Representative use cases
- Pharmacovigilance
- Clinical operations
- Medical affairs AI
- Regulatory writing
- Drug discovery copilots
Ready to assess an AI deployment in Pharmaceuticals & Life Sciences?
Start a free preliminary assessment. We'll scope the engagement and identify the right domain experts for your specific use case.